Semaglutide patients lose an average of 1517% of body weight, while Tirzepatide patients have seen up to 2225%
A 7-day GLP-1 nutrition support plan designed with a registered dietitian
Treatment is individualized and provided under physician supervision as part of a broader rehabilitation strategy
In addition to making products more sustainable through material selection, Ypsomeds Net Zero Program also incorporates optimised packaging solutions, which prioritise the use of recycled materials for trays and a shift to wooden pallets, minimising the overall carbon footprint while ensuring that pharmaceutical logistics maintain the highest quality and safety standards
With a rapidly increasing number of GLP-1 drugs already being prescribed for conditions such as type 2 diabetes, obesity and kidney disease, these results suggest these medications could potentially be repurposed to reduce the risk of no-reflow in heart attack patients
A spokesperson for Eli Lilly, the maker of Mounjaro and Zepbound, told NBC that the company values "efforts to make healthy living easier for everyone."